Indication
Digestive System Neuroendocrine Carcinoma
1 clinical trial
3 drugs
Clinical trial
Phase 2 Single-Arm Study of Nanoliposomal Irinotecan With Fluorouracil and Leucovorin in Refractory Advanced High Grade Neuroendocrine Cancer of GI, Unknown or Pancreatic OriginStatus: Active (not recruiting), Estimated PCD: 2022-10-18
Drug
5-FUDrug
FOLFOXIRI